
Axelyf
Operator of a drug development company intended for metabolic diseases. The company offers astaxanthin material that originates from algae culture and ends as a proprietary prodrug with optimized oral...
Valuation
$0
Share Price
N/A
Total Raised
$8.6M
Last Round
N/A